Collaboration Is the Key to North Texas’ Emergence as a Bio-Hub

"When it comes to the biotech industry, our region is leading the U.S. in key metrics of job growth and investment," write Kathleen Otto and George Goodno. One proof point? VC funding is flowing into DFW at a faster rate than any other area in the nation.

These North Texas life science leaders say the region's success is no coincidence. Here's how the shared ambition of key players and strategic collaboration has impact.
Dallas Biopharma ReCode Therapeutics Closes $80M Series B Round to Expand Drug Pipeline for Respiratory Diseases
by | Oct 21, 2021
The funding, which was co-led by Pfizer Ventures and EcoR1 Capital, will help drive ReCode's therapy programs for primary ciliary dyskinesia and cystic fibrosis into human clinical studies.
Dallas’ Lantern Pharma Hits Major Milestone on its AI Platform to Advance its Oncology Drug Research and Development
by | Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
Is DFW Becoming a Hub for Manufacturing? JLL Says It’s Trending That Way
by | Oct 2, 2017
An increasing number of companies are eyeing North Texas as a location to establish their large-scale manufacturing operations.